2m 2m 2m 2m 2m 2m 2m
Moleculin Btech (MBRX)
NASDAQ
$8.26+$0.20 (+2.48%)
Price as of Nov 11, 2026 7:39 PM EST- $164.3MMarket Cap
- -96.63%1-Year Change
- BiotechnologyIndustry
Moleculin Btech (MBRX)
$8.26+$0.20 (+2.48%)
MBRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $8.06 | ||
Change | -$0.60 (-6.93%) | ||
Open | $8.51 | ||
High | $8.87 | ||
Low | $8.01 | ||
Previous Close | $8.66 | ||
Volume | 20,743 | ||
30-Day Average Volume | 41,821 | ||
1-Week Change | -2.89% | ||
1-Month Change | -8.82% | ||
1-Year Change | -96.63% | ||
3-Year Change | -99.80% | ||
5-Year Change | -99.96% | ||
Fundamentals | |||
Shares Outstanding | 20.4M | ||
Total Assets | $21.1M | ||
Market Cap | $164.3M | ||
Enterprise Value | $157.0M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$7.6M | ||
Free Cash Flow | -$6.7M | ||
EBIT | -$7.6M | ||
EBITDA | -$7.5M | ||
Net Working Capital | -$590,000.00 | ||
EPS | -$28.00 | ||
Enterprise Value/EBITDA | -21 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 14 | ||
P/E | -0 | ||
PEG | -0 | ||
Price/Free Cash Flow | -25 | ||
Price/Operating Cash Flow | -25 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 20 | ||
Last Split Date | 10/20/2026 | ||
Earnings & Revenue